nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A7—Ifosfamide—testicular cancer	0.184	0.235	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.184	0.235	CbGbCtD
Ethosuximide—CYP3A5—Ifosfamide—testicular cancer	0.138	0.176	CbGbCtD
Ethosuximide—CYP2E1—Etoposide—testicular cancer	0.085	0.108	CbGbCtD
Ethosuximide—CYP3A5—Etoposide—testicular cancer	0.066	0.0843	CbGbCtD
Ethosuximide—CYP3A4—Ifosfamide—testicular cancer	0.0539	0.0688	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—testicular cancer	0.0286	0.0365	CbGbCtD
Ethosuximide—CYP3A4—Etoposide—testicular cancer	0.0258	0.0329	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—testicular cancer	0.0176	0.0224	CbGbCtD
Ethosuximide—Fatigue—Chlorambucil—testicular cancer	0.000979	0.00452	CcSEcCtD
Ethosuximide—Leukopenia—Bleomycin—testicular cancer	0.000963	0.00445	CcSEcCtD
Ethosuximide—Immune system disorder—Ifosfamide—testicular cancer	0.000955	0.00441	CcSEcCtD
Ethosuximide—Mediastinal disorder—Ifosfamide—testicular cancer	0.000952	0.0044	CcSEcCtD
Ethosuximide—Aplastic anaemia—Methotrexate—testicular cancer	0.000935	0.00432	CcSEcCtD
Ethosuximide—Hiccups—Epirubicin—testicular cancer	0.000932	0.0043	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Chlorambucil—testicular cancer	0.000928	0.00429	CcSEcCtD
Ethosuximide—Mental disorder—Ifosfamide—testicular cancer	0.000926	0.00428	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.000922	0.00426	CcSEcCtD
Ethosuximide—Malnutrition—Ifosfamide—testicular cancer	0.00092	0.00425	CcSEcCtD
Ethosuximide—Decreased appetite—Vinblastine—testicular cancer	0.000904	0.00418	CcSEcCtD
Ethosuximide—Urticaria—Chlorambucil—testicular cancer	0.000902	0.00416	CcSEcCtD
Ethosuximide—Urinary tract disorder—Cisplatin—testicular cancer	0.0009	0.00416	CcSEcCtD
Ethosuximide—Leukopenia—Dactinomycin—testicular cancer	0.000899	0.00415	CcSEcCtD
Ethosuximide—Abdominal pain—Chlorambucil—testicular cancer	0.000897	0.00414	CcSEcCtD
Ethosuximide—Connective tissue disorder—Cisplatin—testicular cancer	0.000895	0.00414	CcSEcCtD
Ethosuximide—Urethral disorder—Cisplatin—testicular cancer	0.000893	0.00413	CcSEcCtD
Ethosuximide—Aplastic anaemia—Epirubicin—testicular cancer	0.000875	0.00404	CcSEcCtD
Ethosuximide—Agranulocytosis—Etoposide—testicular cancer	0.000868	0.00401	CcSEcCtD
Ethosuximide—Hiccups—Doxorubicin—testicular cancer	0.000862	0.00398	CcSEcCtD
Ethosuximide—Eye disorder—Cisplatin—testicular cancer	0.000851	0.00393	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vinblastine—testicular cancer	0.000851	0.00393	CcSEcCtD
Ethosuximide—Agitation—Ifosfamide—testicular cancer	0.000845	0.0039	CcSEcCtD
Ethosuximide—Anorexia—Bleomycin—testicular cancer	0.000837	0.00387	CcSEcCtD
Ethosuximide—Hypersensitivity—Chlorambucil—testicular cancer	0.000836	0.00386	CcSEcCtD
Ethosuximide—Urinary tract disorder—Etoposide—testicular cancer	0.000824	0.00381	CcSEcCtD
Ethosuximide—Leukopenia—Ifosfamide—testicular cancer	0.000823	0.0038	CcSEcCtD
Ethosuximide—Immune system disorder—Cisplatin—testicular cancer	0.000823	0.0038	CcSEcCtD
Ethosuximide—Abdominal pain—Vinblastine—testicular cancer	0.000822	0.0038	CcSEcCtD
Ethosuximide—Mediastinal disorder—Cisplatin—testicular cancer	0.000821	0.00379	CcSEcCtD
Ethosuximide—Urethral disorder—Etoposide—testicular cancer	0.000818	0.00378	CcSEcCtD
Ethosuximide—Asthenia—Chlorambucil—testicular cancer	0.000814	0.00376	CcSEcCtD
Ethosuximide—Aplastic anaemia—Doxorubicin—testicular cancer	0.000809	0.00374	CcSEcCtD
Ethosuximide—Mental disability—Epirubicin—testicular cancer	0.000808	0.00373	CcSEcCtD
Ethosuximide—Malnutrition—Cisplatin—testicular cancer	0.000793	0.00366	CcSEcCtD
Ethosuximide—Erythema multiforme—Etoposide—testicular cancer	0.000789	0.00365	CcSEcCtD
Ethosuximide—Anorexia—Dactinomycin—testicular cancer	0.000781	0.00361	CcSEcCtD
Ethosuximide—Eye disorder—Etoposide—testicular cancer	0.00078	0.0036	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000778	0.00359	CcSEcCtD
Ethosuximide—Diarrhoea—Chlorambucil—testicular cancer	0.000777	0.00359	CcSEcCtD
Ethosuximide—Hypersensitivity—Vinblastine—testicular cancer	0.000766	0.00354	CcSEcCtD
Ethosuximide—Decreased appetite—Bleomycin—testicular cancer	0.000764	0.00353	CcSEcCtD
Ethosuximide—Muscle spasms—Cisplatin—testicular cancer	0.000762	0.00352	CcSEcCtD
Ethosuximide—Immune system disorder—Etoposide—testicular cancer	0.000754	0.00348	CcSEcCtD
Ethosuximide—Mediastinal disorder—Etoposide—testicular cancer	0.000752	0.00347	CcSEcCtD
Ethosuximide—Mental disability—Doxorubicin—testicular cancer	0.000748	0.00346	CcSEcCtD
Ethosuximide—Asthenia—Vinblastine—testicular cancer	0.000746	0.00345	CcSEcCtD
Ethosuximide—Lethargy—Methotrexate—testicular cancer	0.000737	0.00341	CcSEcCtD
Ethosuximide—Nervous system disorder—Ifosfamide—testicular cancer	0.000736	0.0034	CcSEcCtD
Ethosuximide—Skin disorder—Ifosfamide—testicular cancer	0.000729	0.00337	CcSEcCtD
Ethosuximide—Vomiting—Chlorambucil—testicular cancer	0.000722	0.00333	CcSEcCtD
Ethosuximide—Anorexia—Ifosfamide—testicular cancer	0.000716	0.00331	CcSEcCtD
Ethosuximide—Decreased appetite—Dactinomycin—testicular cancer	0.000712	0.00329	CcSEcCtD
Ethosuximide—Diarrhoea—Vinblastine—testicular cancer	0.000712	0.00329	CcSEcCtD
Ethosuximide—Leukopenia—Cisplatin—testicular cancer	0.00071	0.00328	CcSEcCtD
Ethosuximide—Fatigue—Dactinomycin—testicular cancer	0.000706	0.00326	CcSEcCtD
Ethosuximide—Muscle spasms—Etoposide—testicular cancer	0.000699	0.00323	CcSEcCtD
Ethosuximide—Urticaria—Bleomycin—testicular cancer	0.000698	0.00322	CcSEcCtD
Ethosuximide—Lethargy—Epirubicin—testicular cancer	0.00069	0.00319	CcSEcCtD
Ethosuximide—Irritability—Methotrexate—testicular cancer	0.00069	0.00319	CcSEcCtD
Ethosuximide—Dizziness—Vinblastine—testicular cancer	0.000688	0.00318	CcSEcCtD
Ethosuximide—Ataxia—Methotrexate—testicular cancer	0.00068	0.00314	CcSEcCtD
Ethosuximide—Nausea—Chlorambucil—testicular cancer	0.000674	0.00311	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000671	0.0031	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00067	0.00309	CcSEcCtD
Ethosuximide—Somnolence—Ifosfamide—testicular cancer	0.000667	0.00308	CcSEcCtD
Ethosuximide—Vomiting—Vinblastine—testicular cancer	0.000661	0.00305	CcSEcCtD
Ethosuximide—Breast disorder—Methotrexate—testicular cancer	0.000653	0.00302	CcSEcCtD
Ethosuximide—Decreased appetite—Ifosfamide—testicular cancer	0.000653	0.00301	CcSEcCtD
Ethosuximide—Headache—Vinblastine—testicular cancer	0.000652	0.00301	CcSEcCtD
Ethosuximide—Leukopenia—Etoposide—testicular cancer	0.00065	0.003	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000648	0.00299	CcSEcCtD
Ethosuximide—Abdominal pain—Dactinomycin—testicular cancer	0.000648	0.00299	CcSEcCtD
Ethosuximide—Fatigue—Ifosfamide—testicular cancer	0.000647	0.00299	CcSEcCtD
Ethosuximide—Hypersensitivity—Bleomycin—testicular cancer	0.000647	0.00299	CcSEcCtD
Ethosuximide—Lethargy—Doxorubicin—testicular cancer	0.000639	0.00295	CcSEcCtD
Ethosuximide—Ataxia—Epirubicin—testicular cancer	0.000636	0.00294	CcSEcCtD
Ethosuximide—Nervous system disorder—Cisplatin—testicular cancer	0.000635	0.00293	CcSEcCtD
Ethosuximide—Asthenia—Bleomycin—testicular cancer	0.00063	0.00291	CcSEcCtD
Ethosuximide—Skin disorder—Cisplatin—testicular cancer	0.000629	0.0029	CcSEcCtD
Ethosuximide—Eosinophilia—Methotrexate—testicular cancer	0.000618	0.00286	CcSEcCtD
Ethosuximide—Nausea—Vinblastine—testicular cancer	0.000618	0.00285	CcSEcCtD
Ethosuximide—Abdominal pain upper—Epirubicin—testicular cancer	0.000618	0.00285	CcSEcCtD
Ethosuximide—Anorexia—Cisplatin—testicular cancer	0.000617	0.00285	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000614	0.00284	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000614	0.00284	CcSEcCtD
Ethosuximide—Breast disorder—Epirubicin—testicular cancer	0.000611	0.00282	CcSEcCtD
Ethosuximide—Hypersensitivity—Dactinomycin—testicular cancer	0.000604	0.00279	CcSEcCtD
Ethosuximide—Abdominal discomfort—Methotrexate—testicular cancer	0.000599	0.00277	CcSEcCtD
Ethosuximide—Urticaria—Ifosfamide—testicular cancer	0.000596	0.00275	CcSEcCtD
Ethosuximide—Abdominal pain—Ifosfamide—testicular cancer	0.000594	0.00274	CcSEcCtD
Ethosuximide—Pancytopenia—Methotrexate—testicular cancer	0.000593	0.00274	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—testicular cancer	0.000588	0.00272	CcSEcCtD
Ethosuximide—Asthenia—Dactinomycin—testicular cancer	0.000588	0.00272	CcSEcCtD
Ethosuximide—Eosinophilia—Epirubicin—testicular cancer	0.000579	0.00267	CcSEcCtD
Ethosuximide—Skin disorder—Etoposide—testicular cancer	0.000576	0.00266	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—testicular cancer	0.000572	0.00264	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—testicular cancer	0.000565	0.00261	CcSEcCtD
Ethosuximide—Anorexia—Etoposide—testicular cancer	0.000565	0.00261	CcSEcCtD
Ethosuximide—Decreased appetite—Cisplatin—testicular cancer	0.000563	0.0026	CcSEcCtD
Ethosuximide—Diarrhoea—Dactinomycin—testicular cancer	0.000561	0.00259	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000559	0.00258	CcSEcCtD
Ethosuximide—Vomiting—Bleomycin—testicular cancer	0.000559	0.00258	CcSEcCtD
Ethosuximide—Drowsiness—Methotrexate—testicular cancer	0.000557	0.00257	CcSEcCtD
Ethosuximide—Pancytopenia—Epirubicin—testicular cancer	0.000555	0.00256	CcSEcCtD
Ethosuximide—Rash—Bleomycin—testicular cancer	0.000554	0.00256	CcSEcCtD
Ethosuximide—Dermatitis—Bleomycin—testicular cancer	0.000553	0.00256	CcSEcCtD
Ethosuximide—Hypersensitivity—Ifosfamide—testicular cancer	0.000553	0.00256	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000552	0.00255	CcSEcCtD
Ethosuximide—Asthenia—Ifosfamide—testicular cancer	0.000539	0.00249	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—testicular cancer	0.000535	0.00247	CcSEcCtD
Ethosuximide—Haematuria—Methotrexate—testicular cancer	0.000531	0.00245	CcSEcCtD
Ethosuximide—Weight decreased—Epirubicin—testicular cancer	0.000529	0.00244	CcSEcCtD
Ethosuximide—Somnolence—Etoposide—testicular cancer	0.000527	0.00243	CcSEcCtD
Ethosuximide—Nausea—Bleomycin—testicular cancer	0.000522	0.00241	CcSEcCtD
Ethosuximide—Drowsiness—Epirubicin—testicular cancer	0.000521	0.00241	CcSEcCtD
Ethosuximide—Vomiting—Dactinomycin—testicular cancer	0.000521	0.00241	CcSEcCtD
Ethosuximide—Agranulocytosis—Methotrexate—testicular cancer	0.00052	0.0024	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000517	0.00239	CcSEcCtD
Ethosuximide—Rash—Dactinomycin—testicular cancer	0.000517	0.00239	CcSEcCtD
Ethosuximide—Decreased appetite—Etoposide—testicular cancer	0.000515	0.00238	CcSEcCtD
Ethosuximide—Diarrhoea—Ifosfamide—testicular cancer	0.000514	0.00237	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—testicular cancer	0.000514	0.00237	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000512	0.00236	CcSEcCtD
Ethosuximide—Fatigue—Etoposide—testicular cancer	0.000511	0.00236	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—testicular cancer	0.000497	0.0023	CcSEcCtD
Ethosuximide—Dizziness—Ifosfamide—testicular cancer	0.000496	0.00229	CcSEcCtD
Ethosuximide—Urinary tract disorder—Methotrexate—testicular cancer	0.000494	0.00228	CcSEcCtD
Ethosuximide—Urethral disorder—Methotrexate—testicular cancer	0.00049	0.00226	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—testicular cancer	0.000489	0.00226	CcSEcCtD
Ethosuximide—Nausea—Dactinomycin—testicular cancer	0.000487	0.00225	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—testicular cancer	0.000486	0.00225	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Etoposide—testicular cancer	0.000485	0.00224	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—testicular cancer	0.000482	0.00223	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000478	0.00221	CcSEcCtD
Ethosuximide—Vomiting—Ifosfamide—testicular cancer	0.000477	0.0022	CcSEcCtD
Ethosuximide—Hypersensitivity—Cisplatin—testicular cancer	0.000477	0.0022	CcSEcCtD
Ethosuximide—Rash—Ifosfamide—testicular cancer	0.000473	0.00219	CcSEcCtD
Ethosuximide—Dermatitis—Ifosfamide—testicular cancer	0.000473	0.00218	CcSEcCtD
Ethosuximide—Erythema multiforme—Methotrexate—testicular cancer	0.000473	0.00218	CcSEcCtD
Ethosuximide—Urticaria—Etoposide—testicular cancer	0.000471	0.00218	CcSEcCtD
Ethosuximide—Abdominal pain—Etoposide—testicular cancer	0.000469	0.00217	CcSEcCtD
Ethosuximide—Eye disorder—Methotrexate—testicular cancer	0.000467	0.00216	CcSEcCtD
Ethosuximide—Asthenia—Cisplatin—testicular cancer	0.000464	0.00215	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—testicular cancer	0.000462	0.00213	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—testicular cancer	0.00046	0.00212	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—testicular cancer	0.00046	0.00212	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—testicular cancer	0.000459	0.00212	CcSEcCtD
Ethosuximide—Immune system disorder—Methotrexate—testicular cancer	0.000452	0.00209	CcSEcCtD
Ethosuximide—Mediastinal disorder—Methotrexate—testicular cancer	0.000451	0.00208	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—testicular cancer	0.00045	0.00208	CcSEcCtD
Ethosuximide—Nausea—Ifosfamide—testicular cancer	0.000446	0.00206	CcSEcCtD
Ethosuximide—Diarrhoea—Cisplatin—testicular cancer	0.000443	0.00205	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—testicular cancer	0.000442	0.00204	CcSEcCtD
Ethosuximide—Mental disorder—Methotrexate—testicular cancer	0.000438	0.00202	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—testicular cancer	0.000437	0.00202	CcSEcCtD
Ethosuximide—Hypersensitivity—Etoposide—testicular cancer	0.000437	0.00202	CcSEcCtD
Ethosuximide—Malnutrition—Methotrexate—testicular cancer	0.000435	0.00201	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000428	0.00197	CcSEcCtD
Ethosuximide—Asthenia—Etoposide—testicular cancer	0.000425	0.00197	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—testicular cancer	0.000425	0.00196	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—testicular cancer	0.000424	0.00196	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—testicular cancer	0.000423	0.00195	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—testicular cancer	0.000422	0.00195	CcSEcCtD
Ethosuximide—Vomiting—Cisplatin—testicular cancer	0.000412	0.0019	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—testicular cancer	0.00041	0.00189	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—testicular cancer	0.000409	0.00189	CcSEcCtD
Ethosuximide—Rash—Cisplatin—testicular cancer	0.000408	0.00189	CcSEcCtD
Ethosuximide—Dermatitis—Cisplatin—testicular cancer	0.000408	0.00188	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—testicular cancer	0.000407	0.00188	CcSEcCtD
Ethosuximide—Diarrhoea—Etoposide—testicular cancer	0.000406	0.00187	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—testicular cancer	0.000405	0.00187	CcSEcCtD
Ethosuximide—Dizziness—Etoposide—testicular cancer	0.000392	0.00181	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—testicular cancer	0.000392	0.00181	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—testicular cancer	0.000391	0.00181	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—testicular cancer	0.00039	0.0018	CcSEcCtD
Ethosuximide—Leukopenia—Methotrexate—testicular cancer	0.00039	0.0018	CcSEcCtD
Ethosuximide—Nausea—Cisplatin—testicular cancer	0.000384	0.00178	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—testicular cancer	0.000379	0.00175	CcSEcCtD
Ethosuximide—Vomiting—Etoposide—testicular cancer	0.000377	0.00174	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—testicular cancer	0.000377	0.00174	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—testicular cancer	0.000374	0.00173	CcSEcCtD
Ethosuximide—Rash—Etoposide—testicular cancer	0.000374	0.00173	CcSEcCtD
Ethosuximide—Dermatitis—Etoposide—testicular cancer	0.000374	0.00173	CcSEcCtD
Ethosuximide—Headache—Etoposide—testicular cancer	0.000371	0.00172	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000368	0.0017	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—testicular cancer	0.000365	0.00168	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—testicular cancer	0.000362	0.00167	CcSEcCtD
Ethosuximide—Nausea—Etoposide—testicular cancer	0.000352	0.00163	CcSEcCtD
Ethosuximide—Nervous system disorder—Methotrexate—testicular cancer	0.000348	0.00161	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—testicular cancer	0.000346	0.0016	CcSEcCtD
Ethosuximide—Skin disorder—Methotrexate—testicular cancer	0.000345	0.00159	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000344	0.00159	CcSEcCtD
Ethosuximide—Anorexia—Methotrexate—testicular cancer	0.000339	0.00156	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—testicular cancer	0.000337	0.00156	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—testicular cancer	0.000326	0.00151	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—testicular cancer	0.000323	0.00149	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000319	0.00147	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—testicular cancer	0.000317	0.00146	CcSEcCtD
Ethosuximide—Somnolence—Methotrexate—testicular cancer	0.000316	0.00146	CcSEcCtD
Ethosuximide—Decreased appetite—Methotrexate—testicular cancer	0.000309	0.00143	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000307	0.00142	CcSEcCtD
Ethosuximide—Fatigue—Methotrexate—testicular cancer	0.000306	0.00141	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—testicular cancer	0.000302	0.00139	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—testicular cancer	0.000299	0.00138	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—testicular cancer	0.000295	0.00136	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—testicular cancer	0.000293	0.00135	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Methotrexate—testicular cancer	0.00029	0.00134	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—testicular cancer	0.000289	0.00133	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000287	0.00133	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—testicular cancer	0.000287	0.00132	CcSEcCtD
Ethosuximide—Urticaria—Methotrexate—testicular cancer	0.000282	0.0013	CcSEcCtD
Ethosuximide—Abdominal pain—Methotrexate—testicular cancer	0.000281	0.0013	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—testicular cancer	0.000273	0.00126	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000272	0.00126	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—testicular cancer	0.000267	0.00123	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000266	0.00123	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—testicular cancer	0.000265	0.00122	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—testicular cancer	0.000264	0.00122	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—testicular cancer	0.000263	0.00121	CcSEcCtD
Ethosuximide—Hypersensitivity—Methotrexate—testicular cancer	0.000262	0.00121	CcSEcCtD
Ethosuximide—Asthenia—Methotrexate—testicular cancer	0.000255	0.00118	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000251	0.00116	CcSEcCtD
Ethosuximide—Hypersensitivity—Epirubicin—testicular cancer	0.000245	0.00113	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—testicular cancer	0.000244	0.00113	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—testicular cancer	0.000243	0.00112	CcSEcCtD
Ethosuximide—Diarrhoea—Methotrexate—testicular cancer	0.000243	0.00112	CcSEcCtD
Ethosuximide—Asthenia—Epirubicin—testicular cancer	0.000238	0.0011	CcSEcCtD
Ethosuximide—Dizziness—Methotrexate—testicular cancer	0.000235	0.00108	CcSEcCtD
Ethosuximide—Diarrhoea—Epirubicin—testicular cancer	0.000227	0.00105	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—testicular cancer	0.000227	0.00105	CcSEcCtD
Ethosuximide—Vomiting—Methotrexate—testicular cancer	0.000226	0.00104	CcSEcCtD
Ethosuximide—Rash—Methotrexate—testicular cancer	0.000224	0.00103	CcSEcCtD
Ethosuximide—Dermatitis—Methotrexate—testicular cancer	0.000224	0.00103	CcSEcCtD
Ethosuximide—Headache—Methotrexate—testicular cancer	0.000223	0.00103	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—testicular cancer	0.000221	0.00102	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—testicular cancer	0.00022	0.00102	CcSEcCtD
Ethosuximide—Vomiting—Epirubicin—testicular cancer	0.000211	0.000976	CcSEcCtD
Ethosuximide—Nausea—Methotrexate—testicular cancer	0.000211	0.000974	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—testicular cancer	0.00021	0.000972	CcSEcCtD
Ethosuximide—Rash—Epirubicin—testicular cancer	0.00021	0.000968	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—testicular cancer	0.000209	0.000967	CcSEcCtD
Ethosuximide—Headache—Epirubicin—testicular cancer	0.000208	0.000962	CcSEcCtD
Ethosuximide—Dizziness—Doxorubicin—testicular cancer	0.000203	0.000939	CcSEcCtD
Ethosuximide—Nausea—Epirubicin—testicular cancer	0.000197	0.000912	CcSEcCtD
Ethosuximide—Vomiting—Doxorubicin—testicular cancer	0.000196	0.000903	CcSEcCtD
Ethosuximide—Rash—Doxorubicin—testicular cancer	0.000194	0.000896	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—testicular cancer	0.000194	0.000895	CcSEcCtD
Ethosuximide—Headache—Doxorubicin—testicular cancer	0.000193	0.00089	CcSEcCtD
Ethosuximide—Nausea—Doxorubicin—testicular cancer	0.000183	0.000844	CcSEcCtD
